SundayTrader
23 Apr 2018
Update Bit of a turnaround in today's update. Clearly higher crude prices are now coming through to the equipment suppliers - slightly surprising that the previous announcement was so cautious. As ever ROR stands on a premium rating, but even at this price the immediate future looks good. Will continue to hold.
Our Haven
06 Mar 2018
Profits Rise and.... Profits rise and the share price falls. Looking behind the headlines these are disappointing results. No major growth story here for 2018. With the currency headwinds it is even worse than it looks. Good company well run but at this price it is not attractive. I will see where the share price drops to and look at buying back in probably around 235 as things stand.
II Editor
27 Feb 2018
NEW ARTICLE: UK's best small-cap shares "The superior returns of small cap stocks versus large caps have been well documented on these pages over recent years, supported by evidence going back over two decades.But can this outperformance continue in the face of rising interest rates, ..."[link]
Our Haven
23 Oct 2017
Director Dealing Like the Chairmans/CEO Dealing, shows confidence with the NEDs. See they are also tipped to target 295p. This is a quality company. Think rather than hold I will top up a little.
II Editor
18 Sep 2017
NEW ARTICLE: A catalyst for almost 20% upside at this mid-cap "Cyclical swings in demand for oil and gas make it difficult for companies who operate in this volatile industry. A slump in prices from $116 a barrel to a low of less than $29 not only hurt producers, but also suppliers like LSE:ROR:Rotork who ..."[link]
Our Haven
09 Aug 2017
Re: Cheap it ain't I will hold for now, quality company. Eye on their dividend policy too.
EssentialInvestor
09 Aug 2017
Cheap it ain't Quality it is.A bit too rich for my blood on the current multiple, just imv only.
LK Hyman
28 Jul 2017
Re: CEO Resignation Pharma,It looks all fairly tidy in that the website is already showing Peter France as having disappeared without trace from the board, and giving all the details of his severance terms (fascinating!). It looks all to have been planned in advance which must be some comfort to shareholders ... of which I am not one, but I have long wanted to own this excellent company which has always, thus far, seemed to be too expensive.Mind you, when one looks at the cost savings which the likes of Shell have been making in their op costs, one realises the squeeze that ROR and others must be suffering.LKH on the flybridge
pharmaspecialist
28 Jul 2017
CEO Resignation Tried to understand the real reason for Peter France's sudden resignation from reading the press release but did not succeed as the press release just calls for more investment in product innovation, customer service and efficiencies which I wouldn't think would normally trigger a CEO resignation. I hope the resignation is because the board want to change strategy a bit and reduce exposure to the oil and gas sector. This is still a solidly profitable business with fairly low debt so I am happy to hold and await developments but I do think that some strategic changes may be needed to reflect the company's changing markets.
Our Haven
22 Jun 2017
Director Dealing Good to see the confidence from the CEO and FD
II Editor
25 Nov 2016
NEW ARTICLE: Share of the week: Recovery inevitable "If you need proof that there are always opportunities in challenging markets, look no further than LSE:ROR:Rotork. Thanks to foreign exchange tailwinds and well-timed acquisitions, revenue at the valve control systems firm should reach the top ..."[link]
pharmaspecialist
22 Nov 2016
Re: Trading Update Yes I would agree that these are decent figures. Being able to produce an OK performance in adverse conditions is one of the reasons I purchased shares in this resilient company.
Our Haven
22 Nov 2016
Trading Update Excellent news from the trading update and the market is responding accordingly.
nk1999
21 Sep 2016
Credit Suisse From ADVFN:"Credit Suisse initiated coverage of Rotork and Weir at 'outperform' as it took a look at the pan-European capital goods sector.The bank gave Rotork a 230p price target. "We see Rotork as a high-quality company and while we do not discount a recovery in end markets, we see continued support for earnings from ongoing acquisitions and FX."In addition, the bank said it sees scope for continued consolidation in Process Automation, adding that Rotork is in an attractive asset given its relatively high market shares in niche markets.CS started Weir with a 1,800p price target. The bank said its positive view was based on the potential for earnings upgrades driven by US onshore oil & gas and FX."On valuation we think stability in the mining business provides support and the shares are not pricing in a demanding recovery for O&G."CS pointed out that Weir has historically correlated well with the rig count, where its US team forecasts 28% growth in 2017.It also said Weir has broad currency exposures and is most leveraged to the US, Canadian and Australian dollars, which have strengthened materially.Credit Suisse started coverage of IMI at 'neutral' with a 1,020p price target. It said that given the company's historical below-sector average organic growth of 1.5% in 2007-15, the focus on investment in IT and improving time to market /customer service is reassuring."However, in 2017 we see limited recovery in end markets, high-margin businesses (Critical aftermarket) under pressure and against that backdrop we expect 2017 to represent a transition year."nk
Our Haven
19 Apr 2016
Friday Good news Friday?)
